Michael Feld's most recent trade in Becton, Dickinson And Co. was a trade of 75 Common Stock done at an average price of $181.8 . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Becton, Dickinson and Co. | Michael Feld | EVP, Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 181.84 per share. | 26 Feb 2026 | 75 | 21,308 (0%) | 0% | 181.8 | 13,638 | Common Stock |
| Becton, Dickinson and Co. | Michael Feld | EVP, CRO & Pres. Life Sciences | Sale of securities on an exchange or to another person at price $ 202.73 per share. | 26 Jan 2026 | 75 | 16,431 (0%) | 0% | 202.7 | 15,205 | Common Stock |
| Becton, Dickinson and Co. | Michael Feld | EVP, CRO & Pres. Life Sciences | Sale of securities on an exchange or to another person at price $ 196.08 per share. | 26 Dec 2025 | 74 | 16,506 (0%) | 0% | 196.1 | 14,510 | Common Stock |
| Becton, Dickinson and Co. | Michael Feld | EVP, CRO & Pres. Life Sciences | Sale of securities on an exchange or to another person at price $ 193.36 per share. | 01 Dec 2025 | 75 | 16,580 (0%) | 0% | 193.4 | 14,502 | Common Stock |
| Becton, Dickinson and Co. | Michael Feld | EVP, CRO & Pres. Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2025 | 8,829 | 17,074 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson and Co. | Michael Feld | EVP, CRO & Pres. Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2025 | 419 | 16,655 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson and Co. | Michael Feld | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 186.02 per share. | 27 Oct 2025 | 57 | 8,245 (0%) | 0% | 186.0 | 10,603 | Common Stock |
| Becton, Dickinson and Co. | Michael Feld | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 181.03 per share. | 26 Sep 2025 | 58 | 8,302 (0%) | 0% | 181.0 | 10,500 | Common Stock |
| Becton, Dickinson and Co. | Michael Feld | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 197.98 per share. | 22 Aug 2025 | 57 | 8,360 (0%) | 0% | 198.0 | 11,285 | Common Stock |
| Becton, Dickinson and Co. | Michael Feld | EVP & President, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 20 Aug 2025 | 773 | 8,417 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp | Michael R. Feldschuh | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.89 per share. | 04 Apr 2025 | 2,063 | 212,694 (5%) | 0% | 7.9 | 16,277 | Daxor Common Stock |
| Daxor Corp | Michael R. Feldschuh | Director, Chief Executive Office | Purchase of securities on an exchange or from another person at price $ 8.13 per share. | 26 Mar 2025 | 1,000 | 210,631 (5%) | 0% | 8.1 | 8,130 | Daxor Common Stock |
| Daxor Corp | Michael R. Feldschuh | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.15 per share. | 19 Mar 2025 | 647 | 209,631 (5%) | 0% | 8.1 | 5,273 | Daxor Common Stock |
| Daxor Corp | Michael R. Feldschuh | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.68 per share. | 10 Mar 2025 | 3,360 | 210,852 (5%) | 0% | 7.7 | 25,805 | Daxor Common Stock |
| Daxor Corp | Michael R. Feldschuh | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.72 per share. | 10 Mar 2025 | 1,492 | 208,984 (5%) | 0% | 7.7 | 11,518 | Daxor Common Stock |
| Daxor Corp | Michael R. Feldschuh | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Dec 2024 | 45,000 | 207,492 (5%) | 1% | 0 | Daxor Common Stock | |
| Becton, Dickinson and Co. | Michael Feld | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 10,004 | 10,004 | - | - | Stock Appreciated Rights | |
| Becton, Dickinson and Co. | Michael Feld | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,553 | 9,190 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson and Co. | Michael Feld | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 6,637 | 6,637 (0%) | 0% | 0 | Common Stock | |
| Daxor Corp | Michael Feldschuh | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 30,000 | 30,000 | - | - | Stock Options (right to buy) | |
| Daxor Corp | Michael Feldschuh | CEO & President | Purchase of securities on an exchange or from another person at price $ 9.75 per share. | 24 May 2023 | 2,000 | 160,206 (4%) | 0% | 9.8 | 19,500 | Common Stock |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 19,731 | 166,843 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 19,731 | 71,422 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 14 Jan 2022 | 5,644 | 161,199 (0%) | 0% | 23.8 | 134,440 | Common Stock |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 3,645 | 91,153 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 3,645 | 148,148 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.93 per share. | 13 Jan 2022 | 1,036 | 147,112 (0%) | 0% | 23.9 | 24,791 | Common Stock |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2022 | 25,403 | 94,798 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 7,603 | 69,395 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 7,603 | 147,724 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 11 Jan 2022 | 3,221 | 144,503 (0%) | 0% | 23.8 | 76,724 | Common Stock |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 23,295 | 152,519 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 23,295 | 76,998 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.06 per share. | 09 Dec 2021 | 12,398 | 140,121 (0%) | 0% | 21.1 | 261,102 | Common Stock |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2021 | 39,558 | 100,293 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2021 | 39,558 | 137,700 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.05 per share. | 06 Apr 2021 | 26,843 | 129,224 (0%) | 0% | 25.0 | 672,417 | Common Stock |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2021 | 18,367 | 156,067 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | Michael David Feldman | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2021 | 18,367 | 122,803 | - | - | Performance Shares |